{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:37:16Z","timestamp":1793299036240,"version":"4.5.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273121"],"award-info":[{"award-number":["82273121"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2022JJ20096"],"award-info":[{"award-number":["2022JJ20096"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.urolonc.2025.05.001","type":"journal-article","created":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T13:27:59Z","timestamp":1748611679000},"page":"526.e17-526.e31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Global trends and regional variations in PCa burden: A focus on China's rapid growth"],"prefix":"10.1016","volume":"43","author":[{"given":"Yu","family":"Gan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1050-2882","authenticated-orcid":false,"given":"Hengfeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panpan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2025.05.001_bib0001","first-page":"12","article-title":"Cancer statistics","volume":"74","author":"Siegel","year":"2024","journal-title":"CA: Cancer J Clin"},{"key":"10.1016\/j.urolonc.2025.05.001_bib0002","first-page":"2156","article-title":"DALYs for breast cancer in China, 2000-2050: trend analysis and prediction based on GBD 2019","volume":"42","author":"Yan","year":"2021","journal-title":"Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi"},{"key":"10.1016\/j.urolonc.2025.05.001_bib0003","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.clgc.2020.08.009","article-title":"Overall survival after treatment of localized prostate cancer with Proton Beam therapy, external-beam photon therapy, or brachytherapy","volume":"19","author":"Liu","year":"2021","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.urolonc.2025.05.001_bib0004","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1093\/jnci\/djp122","article-title":"Risk assessment for prostate cancer metastasis and mortality at the time of diagnosis","volume":"101","author":"Cooperberg","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.urolonc.2025.05.001_bib0005","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.34622","article-title":"Incidence, prevalence, and survival of prostate cancer in the UK","volume":"7","author":"Tan","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.urolonc.2025.05.001_bib0006","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.eururo.2017.04.010","article-title":"Prostate cancer management in an ageing population","volume":"72","author":"Grummet","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2025.05.001_bib0007","first-page":"221","article-title":"Cancer incidence and mortality in China, 2022","volume":"46","author":"Zheng","year":"2024","journal-title":"Chinese J Oncol"},{"key":"10.1016\/j.urolonc.2025.05.001_bib0008","first-page":"365","article-title":"Burden of cancer in China: data on disability-adjusted life years","volume":"49","author":"Shi","year":"2015","journal-title":"Chinese J Prev Med"},{"key":"10.1016\/j.urolonc.2025.05.001_bib0009","doi-asserted-by":"crossref","first-page":"63","DOI":"10.14740\/wjon1191","article-title":"Epidemiology of prostate cancer","volume":"10","author":"Rawla","year":"2019","journal-title":"World J Oncol"},{"key":"10.1016\/j.urolonc.2025.05.001_bib0010","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.euf.2015.01.002","article-title":"Impact of early diagnosis of prostate cancer on survival outcomes","volume":"1","author":"van den Bergh","year":"2015","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.urolonc.2025.05.001_bib0011","doi-asserted-by":"crossref","DOI":"10.4178\/epih.e2023038","article-title":"Disease burden of prostate cancer from 2014 to 2019 in the United States: estimation from the Global Burden of Disease Study 2019 and Medical Expenditure Panel Survey","volume":"45","author":"Lin","year":"2023","journal-title":"Epidemiol Health"},{"key":"10.1016\/j.urolonc.2025.05.001_bib0012","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1158\/1055-9965.EPI-16-1046","article-title":"A review of prostate cancer genome-wide association studies (GWAS)","volume":"27","author":"Benafif","year":"2018","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.urolonc.2025.05.001_bib0013","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1002\/ijc.25516","article-title":"Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008","volume":"127","author":"Ferlay","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.urolonc.2025.05.001_bib0014","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.eururo.2016.05.043","article-title":"Global Incidence and mortality for prostate cancer: analysis of temporal patterns and trends in 36 countries","volume":"70","author":"Wong","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2025.05.001_bib0015","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41585-021-00442-8","article-title":"Epidemiology and genomics of prostate cancer in Asian men","volume":"18","author":"Zhu","year":"2021","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.urolonc.2025.05.001_bib0016","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/CEJ.0000000000000890","article-title":"Prostate cancer burden in major BRICS countries, 1990-2019: findings from the 2019 global burden of disease study","volume":"34","author":"Zhang","year":"2025","journal-title":"Eur J Cancer Prev"},{"key":"10.1016\/j.urolonc.2025.05.001_bib0017","first-page":"201","article-title":"The current status of prostate cancer screening strategies and the Chinese expert consensus on prostate cancer screening","volume":"31","author":"Ji-bin","year":"2024","journal-title":"Chin Oncol Clin Rehabil"},{"key":"10.1016\/j.urolonc.2025.05.001_bib0018","first-page":"1","article-title":"Guidelines for screening, early detection and early treatment of prostate cancer in China (2022, Beijing)","volume":"31","author":"He","year":"2022","journal-title":"China Oncol"},{"key":"10.1016\/j.urolonc.2025.05.001_bib0019","article-title":"Burden of prostate cancer in China, 1990-2019: findings from the 2019 global Burden of disease study","volume":"13","author":"Wang","year":"2022","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.urolonc.2025.05.001_bib0020","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/S0140-6736(24)00367-2","article-title":"Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"403","year":"2024","journal-title":"Lancet (Lond Engl)"},{"key":"10.1016\/j.urolonc.2025.05.001_bib0021","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","article-title":"Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systema","volume":"403","year":"2024","journal-title":"Lancet (Lond Engl)"},{"key":"10.1016\/j.urolonc.2025.05.001_bib0022","first-page":"710","article-title":"Burden of prostate cancer and relationship with the human development index (HDI) in Asia: a study of Global Burden disease in 2019","volume":"14","author":"Fathollahi","year":"2023","journal-title":"Casp J Intern Med"},{"key":"10.1016\/j.urolonc.2025.05.001_bib0023","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1016\/j.jacc.2022.11.001","article-title":"Global Burden of Cardiovascular Diseases and Risks Collaboration, 1990-2021","volume":"80","author":"Lindstrom","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.urolonc.2025.05.001_bib0024","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1177\/0049124119882451","article-title":"The age-period-cohort-interaction model for describing and investigating inter-cohort deviations and intra-cohort life-course dynamics","volume":"51","author":"Luo","year":"2022","journal-title":"Sociol. Methods Res"},{"key":"10.1016\/j.urolonc.2025.05.001_bib0025","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1161\/CIRCULATIONAHA.119.042864","article-title":"Time trends in cardiovascular disease mortality across the BRICS: an age-period-cohort analysis of key nations with emerging economies using the global burden of disease study 2017","volume":"141","author":"Zou","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.urolonc.2025.05.001_bib0026","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0895-4356(99)00033-5","article-title":"Age-period-cohort models: a comparative study of available methodologies","volume":"52","author":"Robertson","year":"1999","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.urolonc.2025.05.001_bib0027","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","article-title":"Permutation tests for joinpoint regression with applications to cancer rates","volume":"19","author":"Kim","year":"2000","journal-title":"Stat. Med."},{"key":"10.1016\/j.urolonc.2025.05.001_bib0028","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1002\/sim.3850","article-title":"Comment on \u2018estimating average annual per cent change in trend analysis\u2019 by Clegg L.X., Hankey B.F., Tiwari R., Feuer E.J., Edwards B.K., Stat Med 2009; 28:3670-3682","volume":"29","author":"Muggeo","year":"2010","journal-title":"Stat Med"},{"key":"10.1016\/j.urolonc.2025.05.001_bib0029","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1002\/sim.3733","article-title":"Estimating average annual per cent change in trend analysis","volume":"28","author":"Clegg","year":"2009","journal-title":"Stat Med"},{"key":"10.1016\/j.urolonc.2025.05.001_bib0030","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/ckj\/sfac218","article-title":"Temporal trends in prevalence and mortality for chronic kidney disease in China from 1990 to 2019: an analysis of the Global Burden of Disease Study 2019","volume":"16","author":"Li","year":"2023","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.urolonc.2025.05.001_bib0031","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1158\/1055-9965.EPI-14-0300","article-title":"A web tool for age-period-cohort analysis of cancer incidence and mortality rates","volume":"23","author":"Rosenberg","year":"2014","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.urolonc.2025.05.001_bib0032","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/bimj.201500263","article-title":"Projecting the future burden of cancer: bayesian age-period-cohort analysis with integrated nested Laplace approximations","volume":"59","author":"Riebler","year":"2017","journal-title":"Biom J Biom Z"},{"key":"10.1016\/j.urolonc.2025.05.001_bib0033","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/nrc1781","article-title":"Predicting the future burden of cancer","volume":"6","author":"Bray","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.urolonc.2025.05.001_bib0034","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.eururo.2024.11.013","article-title":"Recent patterns and trends in global prostate cancer incidence and mortality: an update","volume":"87","author":"Schafer","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2025.05.001_bib0035","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/bmb\/ldw050","article-title":"Cancer burden with ageing population in urban regions in China: projection on cancer registry data from World Health Organization","volume":"121","author":"Tsoi","year":"2017","journal-title":"Br Med Bull"},{"key":"10.1016\/j.urolonc.2025.05.001_bib0036","year":"2019","journal-title":"Healthy China Initiative"},{"key":"10.1016\/j.urolonc.2025.05.001_bib0037","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.eururo.2023.04.021","article-title":"2022 Update on prostate cancer epidemiology and risk factors\u2014a systematic review","volume":"84","author":"Bergengren","year":"2023","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2025.05.001_bib0038","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ijrobp.2008.04.004","article-title":"Bowel, urinary, and sexual problems among long-term prostate cancer survivors: a population-based study","volume":"73","author":"Mols","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.urolonc.2025.05.001_bib0039","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1056\/NEJMoa1209978","article-title":"Long-term functional outcomes after treatment for localized prostate cancer","volume":"368","author":"Resnick","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2025.05.001_bib0040","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.eururo.2014.03.002","article-title":"Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies","volume":"66","author":"Pokorny","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2025.05.001_bib0041","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.eururo.2017.11.024","article-title":"Performance of a prostate cancer genomic classifier in predicting metastasis in men with prostate-specific antigen persistence postprostatectomy","volume":"74","author":"Spratt","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2025.05.001_bib0042","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.eururo.2014.05.039","article-title":"Combined value of validated clinical and genomic risk stratification tools for predicting prostate cancer mortality in a high-risk prostatectomy cohort","volume":"67","author":"Cooperberg","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2025.05.001_bib0043","doi-asserted-by":"crossref","DOI":"10.21037\/tau.2018.AB004","article-title":"AB004. Rational and risk-stratified prostate cancer screening and treatment","volume":"7","author":"Cooperberg","year":"2018","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.urolonc.2025.05.001_bib0044","article-title":"Application and optimization of prostate-specific antigen screening strategy in the diagnosis of prostate cancer: a systematic review","volume":"13","author":"Zhang","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.urolonc.2025.05.001_bib0045","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.eururo.2011.08.022","article-title":"Prostate cancer units: has the time come to discuss this thorny issue and promote their establishment in Europe?","volume":"60","author":"Valdagni","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2025.05.001_bib0046","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4236\/oju.2015.53004","article-title":"Clinical stage evaluation at diagnosis of prostate cancer at Urology-Andrology Clinic Cnhu-Hkm Cotonou","volume":"05","author":"Pascal","year":"2015","journal-title":"Open J Urol"},{"key":"10.1016\/j.urolonc.2025.05.001_bib0047","doi-asserted-by":"crossref","first-page":"155","DOI":"10.14740\/wjon1484","article-title":"Radiation therapy for prostate cancer: challenges facing low-middle income countries during COVID Pandemic","volume":"13","author":"Abu-Hijlih","year":"2022","journal-title":"World J Oncol"},{"key":"10.1016\/j.urolonc.2025.05.001_bib0048","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ijrobp.2016.05.022","article-title":"Association between travel distance and choice of treatment for prostate cancer: does geography reduce patient choice?","volume":"96","author":"Muralidhar","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.urolonc.2025.05.001_bib0049","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12301-020-00108-8","article-title":"Prostate cancer awareness and screening among men in a rural community in Kenya: a cross-sectional study","volume":"27","author":"Mbugua","year":"2021","journal-title":"Afr J Urol"},{"key":"10.1016\/j.urolonc.2025.05.001_bib0050","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1177\/1049732312467852","article-title":"Barriers to prostate cancer care: affordable care is not enough","volume":"23","author":"Oduro","year":"2013","journal-title":"Qual Health Res"},{"key":"10.1016\/j.urolonc.2025.05.001_bib0051","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ijrobp.2017.04.002","article-title":"Low-dose-rate brachytherapy for prostate cancer in Low-resource settings","volume":"99","author":"Echevarria","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.urolonc.2025.05.001_bib0052","doi-asserted-by":"crossref","first-page":"e524","DOI":"10.1016\/S1470-2045(13)70451-0","article-title":"Management of prostate cancer in Asia: resource-stratified guidelines from the Asian Oncology Summit 2013","volume":"14","author":"Williams","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.urolonc.2025.05.001_bib0053","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1186\/s12889-021-10793-x","article-title":"Stigma, beliefs and perceptions regarding prostate cancer among Black and Latino men and women","volume":"21","author":"Vapiwala","year":"2021","journal-title":"BMC Public Health"},{"key":"10.1016\/j.urolonc.2025.05.001_bib0054","first-page":"A40","article-title":"85 Cultural responses to prostate cancer in ghana: masculinity and stigma","volume":"9","year":"2019","journal-title":"BMJ Support Palliat Care"},{"key":"10.1016\/j.urolonc.2025.05.001_bib0055","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1158\/1055-9965.EPI-23-1034","article-title":"Trends of prostate cancer morbidity in low-incidence countries from 1990 to 2019","volume":"33","author":"Jiang","year":"2024","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.urolonc.2025.05.001_bib0056","article-title":"Prostate cancer incidence and mortality: global status and temporal trends in 89 countries from 2000 to 2019","volume":"10","author":"Wang","year":"2022","journal-title":"Front Public Health"},{"key":"10.1016\/j.urolonc.2025.05.001_bib0057","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1093\/jnci\/djaa068","article-title":"Prostate cancer incidence 5 years after US preventive Services Task Force recommendations against screening","volume":"113","author":"Jemal","year":"2021","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.urolonc.2025.05.001_bib0058","first-page":"83","article-title":"Rising incidence of prostate cancer in Shanghai, China","volume":"7","author":"Hsing","year":"1998","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.urolonc.2025.05.001_bib0059","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.824464","article-title":"Different trends in the incidence and mortality rates of prostate cancer between China and the USA: a joinpoint and age-period-cohort analysis","volume":"9","author":"He","year":"2022","journal-title":"Front Med"},{"key":"10.1016\/j.urolonc.2025.05.001_bib0060","first-page":"98","article-title":"Advances in epidemiology of prostate cancer in China","volume":"48","author":"Xing","year":"2021","journal-title":"Oncol Prev Treat Res"},{"key":"10.1016\/j.urolonc.2025.05.001_bib0061","first-page":"586","article-title":"Analysis on the trend of prostate cancer incidence and age change in cancer registration areas of China, 2000 to 2014","volume":"52","author":"Gu","year":"2018","journal-title":"Chinese J Prev Med"},{"key":"10.1016\/j.urolonc.2025.05.001_bib0062","doi-asserted-by":"crossref","first-page":"51","DOI":"10.22192\/ijcrms.2017.03.06.008","article-title":"Significance of androgen\/estrogen ratio in prostate cancer and benign prostatic hyperplasia: an eclipsed truth","volume":"3","author":"Tewari","year":"2017","journal-title":"Int J Curr Res Med Sci"},{"key":"10.1016\/j.urolonc.2025.05.001_bib0063","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1158\/1538-7445.AM2016-4315","article-title":"Abstract 4315: effects of increased dietary fat consumption on prostate cancer progression in genetically engineered mice","volume":"76","author":"De Velasco","year":"2016","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2025.05.001_bib0064","first-page":"1013","article-title":"Resources and utilizations of medical service in poverty-stricken areas in China","volume":"34","author":"XIE","year":"2018","journal-title":"Chin J Public Health"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143925001723?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143925001723?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T11:35:51Z","timestamp":1754912151000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143925001723"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":64,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1078143925001723"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2025.05.001","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Global trends and regional variations in PCa burden: A focus on China's rapid growth","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2025.05.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}